MLCAC.PA Lombard & Medot (EURONEXT) -12.26% 05 Feb 2026: €13.60 in focus

MLCAC.PA stock dropped -12.26% to €13.60 at the close on 05 Feb 2026 on a clear volume spike. Volume printed 351 shares versus an average of 1, producing a relative volume of 351.00. The move followed an open at €13.50 and left the security testing near-term support around €13.50–€13.60. We examine what the spike, thin liquidity, and company metrics mean for traders and long-term holders, and supply a model-based outlook and practical trading triggers.

MLCAC.PA stock: volume spike at close

A concentrated volume surge pushed MLCAC.PA to close at €13.60, down €1.90 from the prior close of €15.50. The traded volume was 351 against an average of 1, signalling a statistically significant spike. For a micro-cap listed on EURONEXT, that volume gap amplifies price moves and increases short-term volatility.

Price action and technicals for MLCAC.PA

Momentum indicators show mixed signals: RSI at 57.25 and ADX at 31.88, which suggests a strong trend but neutral momentum. Bollinger middle band sits at €15.04 with a lower band at €12.20, placing the close inside the lower band. Key intraday support is €13.50 and immediate resistance is €15.04 and then the year high €16.80.

Valuation and financial metrics for Lombard & Medot SA

Lombard & Medot reports EPS €0.14 and a trailing PE near 97.14, reflecting low earnings versus price. Book value per share is €28.23 and price-to-book is 0.48, indicating the stock trades below book value. Market cap stands at €6,650,917.00 and current ratio is 7.44, which shows liquidity on the balance sheet but heavy inventory days at 1,136.83, a structural working-capital note investors should watch.

Meyka AI rates MLCAC.PA with a score out of 100

Meyka AI rates MLCAC.PA with a score out of 100: 63.31 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The company shows strong book value but thin trading liquidity and elevated relative debt metrics. These grades are informational only and not personalised financial advice.

Meyka AI’s forecast model projects market targets

Meyka AI’s forecast model projects a yearly price of €15.13, implying an upside of 11.24% from the current €13.60. Monthly and quarterly model points are €13.53 and €12.14 respectively. Forecasts are model-based projections and not guarantees. In absence of sell-side consensus, we frame three scenario price targets: conservative €12.00, base €15.13, and optimistic €16.80.

Sector context, risks and trading considerations

Lombard & Medot sits in Consumer Defensive, Beverages – Wineries & Distilleries. The sector average PE is 24.31; MLCAC.PA’s PE at 97.14 departs from peers. Key risks are low liquidity, elevated inventory days, and net debt measures. For traders, confirm any direction with continued volume above 351 and use tight risk controls given the small free float and micro-cap idiosyncrasies.

Final Thoughts

Key takeaways: MLCAC.PA stock closed at €13.60 on 05 Feb 2026 after a pronounced volume spike of 351 shares versus an average of 1, producing outsized short-term volatility. Technicals show support at €13.50 and resistance near €15.04. Valuation metrics are mixed: price-to-book 0.48 contrasts with a high trailing PE 97.14 and heavy inventory days. Meyka AI’s forecast model projects a yearly target of €15.13, an implied upside of 11.24% from €13.60; forecasts are model-based projections and not guarantees. Given the micro-cap structure and limited liquidity, a cautious approach is sensible: wait for follow-through volume above the session spike for a tactical entry, or treat the name for selective, longer-term value exposure under the base forecast. Meyka AI is the AI-powered market analysis platform used to generate the model output and grade above.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.